CAR T-Cell Therapy Feasible, Safe for Autoimmune Diseases

WEDNESDAY, Feb. 21, 2024 -- CD19 chimeric antigen receptor (CAR) T-cell therapy seems feasible, safe, and efficacious for patients with different autoimmune diseases, according to a study published in the Feb. 22 issue of the New England Journal of...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news